Horizon Therapeutics competitive analysis

Latest publications and patents of Horizon Therapeutics New

Explore the latest publications and patents granted to Horizon Therapeutics, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Horizon Therapeutics

Discover the latest PTAB cases involving Horizon Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Horizon Therapeutics

IPR2018-01550Aug 21, 2018PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2018-00459Jan 12, 2018LUPINHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01769Jul 13, 2017PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01768Jul 13, 2017PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01767Jul 13, 2017PAR PHARMACEUTICALHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01160Mar 27, 2017LUPINHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01159Mar 27, 2017LUPINHORIZON THERAPEUTICSTerminated-Settled
IPR2016-00829Apr 1, 2016LUPINHORIZON THERAPEUTICSFinal Written Decision
IPR2016-00284Dec 4, 2015LUPIN PHARMACEUTICALSHORIZON THERAPEUTICSFinal Written Decision
IPR2016-00283Dec 4, 2015LUPIN PHARMACEUTICALSHORIZON THERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Horizon Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
HORIZON THERAPEUTICS - - - 12Non-Active
LUPIN - 115 - Highly Aggressive
LUPIN PHARMACEUTICALS - - 7 - Highly Aggressive
PAR PHARMACEUTICAL - - 21 - Highly Aggressive